| OAA + liraglutide | insulin + liraglutide | ||
| Number (n) | 149 | 114 | |
| Sex (% males) | 61 | 59 | |
| Age (years) | 56 (±10.4) | 59 (±10.4) | |
| Diabetes duration (years) | 7.3 (±6.0) | 9.8 (0 - 30)+ | |
| BMI (kg/m2) | 34.8 (±6.4) | 36.5 (±6.4) | |
| HbA1c (%)/(mmol/mol) | 8.7 (±1.5)/71 (±16) | 8.7 (±1.5)/71 (±16) | |
| Reduction in HbA1c (%)/(mmol/mol) | –1.3 (±1.5)/–15 (±16)* | –0.8 (±1.2)/–8 (±13)* | |
| Body weight (kg) | 105.2 (±21.3) | 109.2 (±22.1) |
| |
| Reduction in body weight (kg) | –3.5 (±4.1)* | –5.1 (±4.9)* |
| |